Status of activation of circulating vaccine-elicited CD8+ T cells

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2287-2296

  Nielsen, M B ^a   Monsurro, V ^a   Migueles, S A ^a   Wang, E ^a   Perez Diez, A ^a   Lee K , H ^a   Kammula, U ^a   Rosenberg, S A ^a   Marincola, F M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; HLA A ANTIGEN; MELANOMA VACCINE; PEPTIDE; TETRAMER;

ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; MELANOMA; PRIORITY JOURNAL; PROLYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; VACCINATION;

EID: 0034662982     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2287     Document Type: Article

References (41)

1. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
2. Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma
3. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
4. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidence for in vivo priming by tumor cells
5. + melanoma patients have a memory phenotype
6. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
7. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
8. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression
9. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
10. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
11. T-cell epitope mapping by flow cytometry
12. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
13. Differences in frequency distribution of HLA-A2 sub-types between American and Italian Caucasian melanoma patients: Relevance for epitope specific vaccination protocols
14. Quantitative correlation between HLA class 1 allele expression and recognition of melanoma cells by antigen specific cytotoxic T lymphocytes
15. Selective human leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
16. Functional dissociation between local and systemic immune response following peptide vaccination
17. + cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones
18. Phenotypic analysis of antigen-specific T lymphocytes
19. Real time quantitative PCR
20. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood
21. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
22. The avidity spectrum of T ceil receptor interactions accounts for T cell anergy in a double transgenic model
23. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8
24. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
25. From TCR engagement to T cell activation: A kinetic view of T cell behavior
26. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions
27. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
28. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
29. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction
30. Enhanced tumor outgrowth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors
31. Activation or frustration of anti-tumor responses by T-cell-based immune modulation
32. A kinetic basis for T cell receptor repertoire selection during an immune response
33. + T cells specific for EBV in healthy virus carriers
34. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
35. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
36. + T cells in individuals receiving highly active antiretroviral therapy (HAART)
37. + T cells with soluble HLA- A2/Tax 11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
38. + T cells during the primary immune response to Epstein-Barr virus in vivo
39. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
40. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes
41. Expansion of tumor/T cell pairs from fine needle aspirates (FNA) of melanoma metastases